Neoadjuvant Immunotherapy in Head and Neck Cancer: Where we are and where we are going?

.ical

09-12, 08:30–09:00 (Europe/Istanbul), Head & Neck Surgery 2

Sid Puram

This speaker also appears in:

• Risk adaptive neoadjuvant surgery approach for head and neck cancer: lessons learned from the experience